Open AccessVorinostat-An overview
Author(s) -
Aditya Kumar Bubna
Publication year - 2015
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/0019-5154.160511
Subject(s) - vorinostat , medicine , drug , cutaneous t cell lymphoma , lymphoma , disease , oncology , pharmacology , histone deacetylase , mycosis fungoides , biochemistry , chemistry , gene , histone
Vorinostat is a new drug used in the management of cutaneous T cell lymphoma when the disease persists, gets worse or comes back during or after treatment with other medicines. It is an efficacious and well tolerated drug and has been considered a novel drug in the treatment of this condition. Currently apart from cutaneous T cell lymphoma the role of Vorinostat for other types of cancers is being investigated both as mono-therapy and combination therapy